Status:
COMPLETED
The Effect on Depressive Symptoms in ECF Residents With COPD
Lead Sponsor:
Valley Medical Research
Conditions:
Chronic Obstructive Pulmonary Disease
Depression
Eligibility:
All Genders
18-94 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess the effect of treatment with Advair Diskus on depression using the Cornell depression scale in COPD patients in the nursing home.
Detailed Description
We are studying 35 residents in the ECF with a diagnosis of COPD. We are evaluating them for depressive symptoms using the Cornell Depression Scale and the MDS 3.0 section D. We are selecting patients...
Eligibility Criteria
Inclusion
- Adult men and women nursing home residents up to age 95
- Stated diagnosis of COPD or FEV1/FVC \<0.7 or being treated with an anticholinergic
- Presence of depressive symptoms as measured on MDS 3.0 Section D SUM
- Free from conditions likely to be fatal within six months
- Able to read or understand English
- Able and willing to provide informed consent or has a guardian/LAR who can provide informed consent
Exclusion
- Currently pregnant
- Unable to read and understand English
- Free from conditions likely to be fatal within six months
- Enrolled in hospice
- New treatment with antidepressant within the last 90 days.
- Current or recent use (within the last 90 days) of Advair Diskus
- Unwilling or unable to provide informed consent
- Expected to be discharged within 3 months
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00974246
Start Date
October 1 2009
End Date
July 1 2011
Last Update
December 28 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Geriatric Medical Associates
Brooksville, Florida, United States, 34601
2
Valley Medical Research
Centerville, Ohio, United States, 45459